Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Cell Dyscrasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05927571
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Genentech, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT01272466
What this trial is testing

Vaccination With Peptides From Anti-apoptotic Proteins in Relapsed Multiple Myeloma

Who this might be right for
Relapsed Multiple Myeloma
Herlev Hospital 40
Testing effectiveness (Phase 2)UnknownNCT03188172
What this trial is testing

MUK Nine b: OPTIMUM Treatment Protocol

Who this might be right for
Multiple Myeloma
University of Leeds 95
Post-approval studies (Phase 4)Study completedNCT00211211
What this trial is testing

FREE Study - Fracture Reduction Evaluation

Who this might be right for
OsteopeniaOsteoporosisMultiple Myeloma+1 more
Medtronic Spine LLC 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07771361
What this trial is testing

BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple Myeloma

Who this might be right for
Non-Hodgkin Lymphoma Refractory/ RelapsedMultiple Myeloma RefractoryMultiple Myeloma in Relapse+5 more
Luminary Therapeutics 90
Early research (Phase 1)UnknownNCT04836871
What this trial is testing

Double Filtration Plasmapheresis Combined With Chemotherapy

Who this might be right for
Multiple Myeloma
Fuling Zhou 20
Early research (Phase 1)Study completedNCT03111992
What this trial is testing

Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Novartis Pharmaceuticals 26
Testing effectiveness (Phase 2)Study completedNCT00599495
What this trial is testing

Matched Unrelated Donor Stem Cell Transplantation (MUD-SCT) After Dose-reduced Conditioning for Patients With Multiple Myeloma and Relapse After Autologous SCT

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 50
Testing effectiveness (Phase 2)Study completedNCT03477539
What this trial is testing

Daratumumab in Treating Transplant-Eligible Patients With Multiple Myeloma

Who this might be right for
Plasma Cell Myeloma
Mayo Clinic 49
Not applicableStudy completedNCT01752075
What this trial is testing

A Non-interventional, Observational Post-marketing Registry of Patients Treated With Revlimid (Lenalidomide) in Taiwan

Who this might be right for
Multiple Myeloma
Celgene 100
Testing effectiveness (Phase 2)Study completedNCT01596257
What this trial is testing

Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center 116
Very early researchNot Yet RecruitingNCT06298266
What this trial is testing

To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Guangdong Second Provincial General Hospital 15
Not applicableStudy completedNCT00476294
What this trial is testing

Long-Term Follow Up Study for AMD3100 Patients

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 7
Large-scale testing (Phase 3)UnknownNCT00014339
What this trial is testing

Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Medsearch
Testing effectiveness (Phase 2)Study completedNCT00448357
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 54
Not applicableStudy completedNCT05724966
What this trial is testing

Anti-neoplastic Treatment, Based on PRO Data Reported Through a MHealth App Solution in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Thomas Lund 33
Testing effectiveness (Phase 2)Looking for participantsNCT05243212
What this trial is testing

Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapse Multiple Myeloma
Sheba Medical Center 75
Not applicableLooking for participantsNCT03858205
What this trial is testing

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma

Who this might be right for
Bone PainMetastatic Malignant Neoplasm in the BonePlasma Cell Myeloma
University of Southern California 100
Early research (Phase 1)Looking for participantsNCT07200102
What this trial is testing

Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 20
Not applicableStudy completedNCT01362972
What this trial is testing

Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor

Who this might be right for
LymphomaMultiple Myeloma
Genzyme, a Sanofi Company 7,801
Next Page